Diagnostic challenges and clinical management of inflammatory myofibroblastic tumor: a retrospective case series study

IMT is a tumor with "low malignant potential" or "borderline" characteristics. It is neither a typical benign tumor nor a highly malignant cancer, but occupies an intermediate gray zone. It can occur at multiple sites in the body, most commonly in the lungs, and has been reported across all age groups. Through the analysis of six cases of IMT with unusual primary sites, this study found that even with low-grade pathological features, the tumor can still exhibit aggressive biological behavior, including postoperative recurrence and distant metastasis, when arising in atypical locations such as the sacrum or nasal cavity. This suggests that the clinical management of IMT should not rely solely on pathological grading but should also involve a comprehensive evaluation incorporating the tumor's location and size. This case series contributes to broadening the understanding of the clinical spectrum of IMT, enhances awareness of IMT in rare sites, and provides important clinical rationale for long-term systematic follow-up and monitoring for all patients with IMT.

Authors

Institutions

Publication Details

Journal
Translational Cancer Research
Published
2025-12-01
DOI
https://doi.org/10.21037/tcr-2025-1-2571
Primary Topic
IgG4-Related and Inflammatory Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Diagnostic challenges and clinical management of inflammatory myofibroblastic tumor: a retrospective case series study

Cheng Zha, W R Li, LI Guo-bing, Q Wang et al.
Translational Cancer Research
IgG4-Related and Inflammatory Diseases
article

Diagnostic challenges and clinical management of inflammatory myofibroblastic tumor: a retrospective case series study

Cheng Zha, W R Li, LI Guo-bing, Q Wang, Bo Chen, Ling-Yu He, Xuefeng Peng, Yue Li, Xiao Yu, Sui-yang Jin, Xin-Wen Wang, Sheng-Han Xu
article en

Abstract

IMT is a tumor with "low malignant potential" or "borderline" characteristics. It is neither a typical benign tumor nor a highly malignant cancer, but occupies an intermediate gray zone. It can occur at multiple sites in the body, most commonly in the lungs, and has been reported across all age groups. Through the analysis of six cases of IMT with unusual primary sites, this study found that even with low-grade pathological features, the tumor can still exhibit aggressive biological behavior, including postoperative recurrence and distant metastasis, when arising in atypical locations such as the sacrum or nasal cavity. This suggests that the clinical management of IMT should not rely solely on pathological grading but should also involve a comprehensive evaluation incorporating the tumor's location and size. This case series contributes to broadening the understanding of the clinical spectrum of IMT, enhances awareness of IMT in rare sites, and provides important clinical rationale for long-term systematic follow-up and monitoring for all patients with IMT.

Translational Cancer ResearchVol. 14(12)
Guiyang Medical University (CN), Soochow University (CN), Affiliated Hospital of Guizhou Medical University (CN), Guiyang University (CN)
Good health and well-being
Openalex Percentile: Top 26%
IgG4-Related and Inflammatory Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.